CRBN expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.717660E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.503400E-01
Normal-vs-Stage2
1.589900E-02
Normal-vs-Stage3
1.136010E-01
Normal-vs-Stage4
5.111400E-01
Stage1-vs-Stage2
3.622000E-01
Stage1-vs-Stage3
2.401700E-02
Stage1-vs-Stage4
6.693000E-01
Stage2-vs-Stage3
1.076870E-03
Stage2-vs-Stage4
1.763200E-01
Stage3-vs-Stage4
6.847800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.482170E-02
Normal-vs-AfricanAmerican
2.035600E-01
Normal-vs-Asian
1.151760E-01
Caucasian-vs-AfricanAmerican
6.892800E-01
Caucasian-vs-Asian
8.146800E-01
AfricanAmerican-vs-Asian
7.139600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.190490E-02
Normal-vs-Female
3.606400E-02
Male-vs-Female
2.388000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.791000E-01
Normal-vs-Age(41-60Yrs)
6.389600E-02
Normal-vs-Age(61-80Yrs)
1.247520E-02
Normal-vs-Age(81-100Yrs)
1.883760E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.720440E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.17169999999967E-05
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.751890E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.083600E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.553980E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.406800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.916090E-02
Normal-vs-Daily Drinker
9.504100E-03
Normal-vs-Weekly Drinker
3.718400E-02
Normal-vs-Occasional Drinker
2.255700E-02
Normal-vs-Social Drinker
1.744550E-01
Non Drinker-vs-Daily Drinker
4.409200E-01
Non Drinker-vs-Weekly Drinker
7.905200E-01
Non Drinker-vs-Occasional Drinker
5.521200E-01
Non Drinker-vs-Social Drinker
2.718600E-01
Daily Drinker-vs-Weekly Drinker
7.121600E-01
Daily Drinker-vs-Occasional Drinker
1.839640E-01
Daily Drinker-vs-Social Drinker
1.084250E-01
Weekly Drinker-vs-Occasional Drinker
4.417800E-01
Weekly Drinker-vs-Social Drinker
2.842200E-01
Occasional Drinker-vs-Social Drinker
5.448400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.842200E-02
Normal-vs-Grade 2
2.092400E-02
Normal-vs-Grade 3
9.119700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.180200E-01
Grade 1-vs-Grade 3
2.869200E-01
Grade 1-vs-Grade 4
7.842200E-02
Grade 2-vs-Grade 3
8.561600E-01
Grade 2-vs-Grade 4
2.092400E-02
Grade 3-vs-Grade 4
9.119700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.545600E-02
Normal-vs-NonDiabetic
7.657500E-03
Diabetic-vs-NonDiabetic
9.467800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.919600E-02
Normal-vs-NoPancreatitis
9.996900E-03
Pancreatitis-vs-NoPancreatitis
4.438000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.899900E-02
Normal-vs-N1
1.381890E-02
N0-vs-N1
7.958400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.610000E-02
Normal-vs-TP53-NonMutant
1.463830E-01
TP53-Mutant-vs-TP53-NonMutant
2.536200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
